EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Vortioxetine–Lurasidone Augmentation for Compulsive Scratching Behavior in Prader–Willi Syndrome: A Case Report

Yasuhide Nagoshi iD

Neuropsychopharmacology Reports · 2026-06 · 46 (2)

DOI: 10.1002/npr2.70145 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Neuropsychopharmacology Reports, online erschienen am 17.06.2026. Verfasst von Yasuhide Nagoshi. Beteiligte Einrichtung: Department of Psychiatry, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan. Hauptthemen laut MEDLINE: Lurasidone Hydrochloride, Prader-Willi Syndrome, Vortioxetine, Compulsive Behavior. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prader–Willi syndrome (PWS) is a rare genetic disorder frequently associated with repetitive and self‐injurious behaviors such as skin picking. Effective pharmacological treatments for compulsive scratching behavior in PWS remain limited. Case Presentation We report the case of a 19‐year‐old woman with PWS presenting with severe, persistent scratching behavior resulting in repeated excoriations. Escitalopram produced partial improvement but was discontinued because of sedation. Treatment was switched to vortioxetine, which reduced the frequency of scratching but did not achieve remission. Subsequent augmentation with lurasidone resulted in marked improvement, with episodes decreasing from daily occurrences to once every 1–3 months and lasting only a few minutes. The patient remained stable for 2 years without recurrence of severe symptoms.

Conclusion

This case suggests that vortioxetine and lurasidone may represent a potential pharmacological option for severe scratching behavior in PWS. Further studies are needed to clarify the therapeutic role of this combination approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lurasidone HydrochloridePrader-Willi SyndromeVortioxetineCompulsive BehaviorExcoriation DisorderHumansFemaleYoung AdultDrug Therapy, Combination

Stichwörter der Autor:innen

Prader–Willi syndromelurasidoneobsessive‐compulsive–related symptomsskin pickingvortioxetine

Substanzen

Lurasidone HydrochlorideVortioxetine

Autor:innen und Institutionen

  • Department of Psychiatry, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.

ORCID-Profile: Yasuhide Nagoshi

Zitieren

APA

Nagoshi, Y. (2026). Vortioxetine–Lurasidone Augmentation for Compulsive Scratching Behavior in Prader–Willi Syndrome: A Case Report. Neuropsychopharmacology Reports, 46(2). https://doi.org/10.1002/npr2.70145

Vancouver

Nagoshi Y. Vortioxetine–Lurasidone Augmentation for Compulsive Scratching Behavior in Prader–Willi Syndrome: A Case Report. Neuropsychopharmacology Reports. 2026;46(2). doi:10.1002/npr2.70145

BibTeX
@article{Nagoshi2026,
  author = {Nagoshi, Yasuhide},
  title = {Vortioxetine–Lurasidone Augmentation for Compulsive Scratching Behavior in Prader–Willi Syndrome: A Case Report},
  journal = {Neuropsychopharmacology Reports},
  year = {2026},
  volume = {46},
  number = {2},
  doi = {10.1002/npr2.70145}
}
Kostenlos starten →